The SULSA Assay Development Fund: accelerating translation of new biology from academia to pharma

Drug Discovery Today

Volumn 22, Issue 2, 2017, Pages 199-203

  McElroy, Stuart P ^a   Jones, Philip S ^a   Barrault, Denise V ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; CAPACITY BUILDING; COST EFFECTIVENESS ANALYSIS; DRUG DEVELOPMENT; DRUG INDUSTRY; FUNDING; HIGH THROUGHPUT SCREENING; HUMAN; KNOWLEDGE; MEDICAL EDUCATION; MEDICAL STUDENT; QUALITY CONTROL; SCIENTIST; SHORT SURVEY; STANDARD; TRANSLATIONAL RESEARCH; FINANCIAL MANAGEMENT; STUDENT; UNIVERSITY;

DRUG DISCOVERY; DRUG INDUSTRY; FINANCIAL MANAGEMENT; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; STUDENTS; TRANSLATIONAL MEDICAL RESEARCH; UNIVERSITIES;

EID: 84991204451     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2016.09.028     Document Type: Short Survey

References (10)

1. 1 Paillard, G., et al. The ELF Honest Data Broker: informatics enabling public–private collaboration in a precompetitive arena. Drug Discov. Today 21 (2016), 97–102.
2. 2 Kingwell, K., European Lead Factory hits its stride. Nat. Rev. Drug Discov. 15 (2016), 221–222.
3. 3 Jones, P., et al. The importance of triaging in determining the quality of output from high-throughput screening. Future Med. Chem. 7 (2015), 1847–1852.
4. 4 Everett, J.R., Academic drug discovery: current status and prospects. Expert Opin. Drug Discov. 10 (2015), 937–944.
5. 5 Tralau-Stewart, C., et al. UK academic drug discovery. Nat. Rev. Drug Discov. 13 (2014), 15–16.
6. 6 Shanks, E., et al. Academic drug discovery within the United Kingdom: a reassessment. Nat. Rev. Drug Discov., 14, 2015, 510.
7. 7 Reichman, M., Simpson, P.B., Open innovation in early drug discovery: roadmaps and roadblocks. Drug Discov. Today 21 (2016), 779–788.
8. 8 Dahlin, J.L., et al. Mitigating risk in academic preclinical drug discovery. Nat. Rev. Drug Discov. 14 (2015), 279–294.
9. 9 Besnard, J., et al. The Joint European Compound Library: boosting precompetitive research. Drug Discov. Today 20 (2015), 181–186.
10. 10 Karawajczyk, A., et al. Expansion of chemical space for collaborative lead generation and drug discovery: the European Lead Factory Perspective. Drug Discov. Today 20 (2015), 1310–1316.